Combined Ketamine and eCBT Intervention for PTSD

Last updated: August 8, 2022
Sponsor: Queen's University
Overall Status: Active - Recruiting

Phase

2

Condition

Anxiety Disorders

Post-traumatic Stress Disorders

Panic Disorders

Treatment

N/A

Clinical Study ID

NCT04771767
14521759
  • Ages 18-65
  • All Genders

Study Summary

An open label RCT assessing the efficacy of a combined treatment approach for PTSD, using Ketamine infusions and online Cognitive Behavioural Therapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of PTSD by a psychiatrist on the team using the Clinician Administered PTSDScale (CAPS-5) with a score of at least 50 and a medium presentation.
  • Patients will have received at least 2 different types of prior treatment, both ofwhich produced less than a 50% reduction in the participant's symptoms.
  • Participants with hypertension or cardiovascular disease must be receiving stabletreatment to participate.
  • Participants must speak and read English, and will have consistent and reliable accessto the internet.
  • Patients with suicidal ideation will be included.
  • Patients with a history of substance abuse will be included (except for opioid usedisorder).

Exclusion

Exclusion Criteria: Hypomanic/manic episodes, bipolar disorder, acute psychosis, opioid use disorder, treatmentwith Naltrexone, pregnancy, postpartum, breastfeeding, untreated hypertension,cardiovascular disease, ASPD, active homicidal ideation, and general noncompliance with thestudy protocol.

Study Design

Total Participants: 16
Study Start date:
August 01, 2021
Estimated Completion Date:
March 31, 2024

Study Description

OBJECTIVES

(i) To introduce a previously untreated patient population with PTSD to new therapeutic options.

(ii) To provide new insights into the functional role of Glutamate in affective disorders as well as in learning and memory.

(iii) To explore the utility of pharmacologically-enhanced psychotherapy.

OUTLINE

The present study is an open label randomized control trial assessing the efficacy of a combined treatment of sub-anaesthetic IV Ketamine in conjunction with online CBT (eCBT). In the study, 16 participants with refractory PTSD will be assigned either to an experimental group receiving a combination of Ketamine and eCBT over 12 weeks, or they will be assigned to a 12-week control group. Both groups will be assessed for symptoms of PTSD and comorbid disorders before treatment, at 2 midway points (4 and 8 weeks), and at the end of the 12 week experimental period. Symptoms of PTSD and comorbid disorders for participants in the experimental group are expected to improve significantly more than participants in the control.

Connect with a study center

  • Queen's University

    Kingston, Ontario K7L 3N6
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.